title: [Management of adverse events due to antineoplastic agents].
authors.forename: Kazunori
authors.initials: K
authors.lastname: Matsuura
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000008:administration & dosage; D000068818:Cetuximab; D002945:Cisplatin / Q000009:adverse effects; D000075202:Contraindications; D004232:Diuretics / Q000008:administration & dosage; D005440:Fluid Therapy; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006509:Hepatitis B / Q000517:prevention & control; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D007684:Kidney Tubules; D017563:Lung Diseases, Interstitial / Q000139:chemically induced; D008274:Magnesium / Q000008:administration & dosage; D009325:Nausea / Q000139:chemically induced* / Q000517:prevention & control*; D010348:Patient Care Team; D017751:Safety Management; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D004232:Diuretics; C413685:entecavir; D006147:Guanine; D008274:Magnesium; D000068818:Cetuximab; D002945:Cisplatin